Moreover, multiple other miRNAs, such as miR-9 (Ao et al., 2016) and miR-34a (Kim et al., 2015), also target Sirt1 and facilitate NAFLD progression via promoting lipogenesis. This evidence concerns the gene SIRT1 and metabolic dysfunction-associated steatotic liver disease.